Pacira Pharma (PCRX) Tops Q2 EPS by 3c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Pacira Pharma (PCRX) Tops Q2 EPS by 3c, Revenues Beat

Pacira BioSciences Reports Second Quarter 2020 Financial Results and Business Update

August 6, 2020 8:00 AM EDT

-- EXPAREL average daily sales return to year-over-year growth in month of June 2020 ---- Conference call today at 8:30 a.m. ET --

PARSIPPANY, N.J., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), a leading provider of innovative non-opioid pain management options, today reported financial results for the second quarter of 2020.

We are very pleased to report that since the peak of the impact from COVID-19 in April, weve seen a steady and continued increase in EXPAREL sales. This is a testimony to the resolve... More